Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2008
11/27/2008CA2687558A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
11/27/2008CA2687264A1 Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
11/27/2008CA2686920A1 Hydrogel materials
11/27/2008CA2686720A1 Drug delivery system with scleral lens
11/27/2008CA2686488A1 Colored esmolol concentrate
11/27/2008CA2686137A1 Improved depot formulations
11/27/2008CA2683283A1 Phospholipid compositions for contact lens care and preservation of pharmaceutical compositions
11/27/2008CA2683276A1 Ziprasidone formulations
11/27/2008CA2680433A1 Novel composition based on cholest-4-ene-3-one oxime
11/27/2008CA2677743A1 Lotion composition for personal use
11/26/2008EP1994948A2 Method for producing hydrogel composition comprising crosslinked polyethylene oxide
11/26/2008EP1994946A1 Polysaccharides cross-linked by ether bonds, their preparation and biomedical applications
11/26/2008EP1994945A1 "Amido-phosphonate or amido-bisphosphonate derivatives of carboxylated polysaccharides, preparation and biomedical uses thereof"
11/26/2008EP1994944A1 Polymer conjugate compounds for the inhibition of apoptosis
11/26/2008EP1994938A1 New lipoglycodepsipeptide compositions
11/26/2008EP1994937A2 Prevention and treatment of amyloidogenic disease
11/26/2008EP1994933A1 Aqueous composition
11/26/2008EP1994157A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
11/26/2008EP1994146A1 Cancerous disease modifying antibody 141205-02
11/26/2008EP1994081A1 Novel poly(ethylene oxide)-block-poly(ester) block copolymers
11/26/2008EP1994062A1 Aryl/alkyl vinyl sulfone hyaluronic acid derivatives
11/26/2008EP1993673A2 Injectable combination therapy for eye disorders
11/26/2008EP1993613A2 Chelating conjugates having a substituted aromatic moiety and derivatives thereof
11/26/2008EP1993610A2 Process for preparing water-soluble polyethylene glycol conjugates of macrolide immunosuppressants
11/26/2008EP1993609A2 Agent-enriched nanoparticles based on hydrophilic proteins
11/26/2008EP1993608A1 Anticancer drugs conjugated to antibody via an enzyme cleavable linker
11/26/2008EP1993557A2 Novel epoprostenol formulation and method of making thereof
11/26/2008EP1993549A1 Medicament formulations comprising fluoroquinolones
11/26/2008EP1993510A1 Medicament containing fluoroquinolones
11/26/2008EP1534246B1 Sustained release pharmaceutical composition of a cephalosporin antibiotic
11/26/2008EP1523239B1 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes
11/26/2008EP1473300B1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases
11/26/2008EP1392258B1 Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
11/26/2008EP1381382B1 Methods and compositions for the treatment of diseases of the eye
11/26/2008EP1370228B1 Systems for delivering a cosmetic and/or therapeutic active to oral surfaces
11/26/2008EP1173481B1 Inactivated cytokines for immunisation
11/26/2008EP0957943B2 Matrix-free osteogenic devices, implants and methods of use thereof
11/26/2008EP0735893B1 Pan dr-binding peptides for enhancement of the immune response
11/26/2008CN101312989A Monoclonal antibodies against claudin-18 for treatment of cancer
11/26/2008CN101312987A Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia
11/26/2008CN101312748A 抗体-药物轭合物和使用方法 Antibodies - drug conjugates and methods of use
11/26/2008CN101312747A Anticoagulant antithrombotic dual inhibitors comprising a biotin label
11/26/2008CN101312711A Pharmaceutical composition free from dexpanthenol, calcium ions, and phosphate, and use of calcium chelating agent and ophthalmologically compatible viscosity regulator
11/26/2008CN101312710A Long acting injectable parasiticidal formulations
11/26/2008CN101312662A High-potency sweetener composition with antioxidant and compositions sweetened therewith
11/26/2008CN101311197A Degradable pH-sensitive hydrogel copolymer method for preparing same and use
11/26/2008CN101311188A Small molecule peptides inhibitor of human heparinase
11/26/2008CN101310770A Antibodies against cancer
11/26/2008CN101310736A External medicine for treating coronary heart disease and preparation method thereof
11/26/2008CN101310734A Chinese and western combine compound uterus perfusate for treating cow endometritis
11/26/2008CN101310728A Free protein blood of pig injection and use thereof
11/26/2008CN101310726A Alcohol-containing polyhexamethylguanidine iodine disinfectant and preparation method thereof
11/26/2008CN101310720A Preparation method of artemether drop pills for treating malaria
11/26/2008CN101310717A Tanshinone óA polylactic acid nano particles and preparation method thereof
11/26/2008CN101310712A Nifedipine controlled release preparation and preparation method thereof
11/26/2008CN101310711A Levo-cetirizine hydrochloride orally disintegrating tablets and preparation method thereof
11/26/2008CN101310709A Preparation method of dihydroartemisinin drop pills for treating malaria
11/26/2008CN100436525C Prepn of sodium alginate/chitosan mixture gel
11/26/2008CN100436477C Cyclic peptide containing arginine, glycine, asparagicacid-sequence and active target liposome
11/26/2008CN100436466C Association compound of trehalose or maltitol with metal ion compound
11/26/2008CN100436415C Process for the preparation of (R)-& alpha, -(2,3-dimethoxyp-henyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
11/26/2008CN100435879C Electro-powder
11/26/2008CN100435847C Continuing release recipe of containing infusible basic remedy
11/26/2008CN100435807C Pharmaceutical gel composition
11/26/2008CN100435790C EGCG-zinc complex solid dispersion, its preparation method and application
11/26/2008CN100435653C Flavor-active peptides
11/25/2008US7456306 Stearate composition and method of production thereof
11/25/2008US7456265 Carriers for cosmetics, pharmaceuticals, and veterinary products providing timed releasing of active ingredients
11/25/2008US7456264 Human monoclonal antibodies against Bacillus anthracis protective antigen
11/25/2008US7456254 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein about 3%-5% (w/w) exendin-4 and about 2% (w/w) sucrose; antidiabetic agent
11/25/2008US7456213 PEG-poly(ortho ester) graft copolymers and pharmaceutical compositions
11/25/2008US7456160 Sustained release; injection of fulvestrant; using 7 alpha -[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17 beta -diol to treat hormonal dependent benign or malignant disease of the breast or reproductive tract
11/25/2008US7456159 For delivering therapeutically effective amount of a drug that includes a parent drug and a prodrug; for delivering steroids
11/25/2008US7456147 Controlled release of active agents utilizing repeat sequence protein polymers
11/25/2008US7456146 Anticarcinogenic agents for use in the treatment of cancer
11/25/2008US7456009 Adenovirus formulations
11/25/2008US7455986 Heparinase III and methods of specifically cleaving therewith
11/25/2008US7455855 Obtained by reacting polyalkylene glycol or a reactive derivative, a phospholipid and a drug with each other to form covalent bonds to form a delivery substance
11/25/2008CA2433032C Sustained release drug delivery devices with coated drug cores
11/25/2008CA2383212C Controlled release oral dosage suitable for oral administration
11/25/2008CA2375549C Delivery system for biological material
11/25/2008CA2370565C Dermally applicable vitamin d-containing pharmaceutical compositions
11/25/2008CA2344680C Enteric and colonic delivery using hpmc capsules
11/25/2008CA2320182C Compositions containing organic compounds
11/25/2008CA2306508C Production of a directly compressible tabletting aid
11/25/2008CA2264776C Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
11/25/2008CA2221418C Insecticidal combination effective against fleas on mammals, particularly cats and dogs
11/25/2008CA2140971C A stable freeze-dried hirudin composition
11/20/2008WO2008141326A1 Biodegradable peptide releasing polymers
11/20/2008WO2008141111A2 Polymers conjugated with platinum drugs
11/20/2008WO2008141110A2 Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs
11/20/2008WO2008141107A2 Compositions that include a hydrophobic compound and a polyamino acid conjugate
11/20/2008WO2008140595A2 Synthetic trivalent haptens, complexes thereof, and uses therefor
11/20/2008WO2008140507A2 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
11/20/2008WO2008140372A1 Coated oral nicotine formulation buffered with amino acid
11/20/2008WO2008140371A1 Oral nicotine formulation buffered with amino acid
11/20/2008WO2008140203A1 Phospholipid nanospheres for solubilization of diterpenoid alkaloid and preparation
11/20/2008WO2008140081A1 Liposome and method for producing liposome
11/20/2008WO2008139855A1 Polyamidoamine dendron-bearing lipid containing lower acyl group
11/20/2008WO2008139804A1 Low-molecule drug-containing nanoparticle having sustained release negatively charged group
1 ... 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 ... 1712